The metabolic profiles of an independent anti-PD-L1 immunotherapy cohort derived from bladder cancer tissue (also squamous carcinoma tissue) were also classified into three clusters with NMF based on RNA-seq data. This evidence concerns the gene CD274 and urinary bladder carcinoma.